Clindacin P

Last updated on RxList: 6/8/2017
Clindacin P Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

Last reviewed on RxList 06/13/2017

Clindacin P (clindamycin phosphate topical solution, 1%) is an antibiotic indicated in the treatment of acne vulgaris. Clindacin P is available in generic form. Common side effects of Clindacin P include:

  • skin burning,
  • itching,
  • dryness,
  • redness,
  • peeling, or
  • oiliness.

Use a pledget to apply a thin film dose of Clindacin P topical solution to the affected area twice daily. More than one pledget may be used. Each pledget should be used only once and then discarded. Clindacin P may interact with neuromuscular blocking agents. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using Clindacin P; it is not expected to harm a fetus when used in the second and third trimesters. It is unknown if Clindacin P would affect a fetus if used in the first trimester. It is unknown if Clindacin P passes into breast milk. Consult your doctor before breastfeeding.

Our Clindacin P (clindamycin phosphate topical solution, 1%) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


Acne is the result of an allergy. See Answer
Clindacin P Professional Information

3 pharmacies near 20147 have coupons for Clindacin-P (Clindamycin Phosphate) (Brand Names:Clindacin P for 60 Swab)

Wegmans Food Markets Inc
Wegmans Food Markets Inc

Est. Regular Price


with free coupon

View Coupon


In 18 clinical studies of various formulations of topical clindamycin phosphate using placebo vehicle and/or active comparator drugs as controls, patients experienced a number of treatment emergent adverse dermatologic events [see table below].

Number of Patients Reporting Events

Treatment Emergent Solution Gel Lotion
Adverse Event n=553 (%) n=148 (%) n=160 (%)
Burning 62 (11) 15 (10) 17 (11)
Itching 36 (7) 15 (10) 17 (11)
Burning/Itching 60 (11) # ( – ) # ( – )
Dryness 105 (19) 34 (23) 29 (18)
Erythema 86 (16) 10 (7) 22 (14)
Oiliness/Oily Skin 8 (1) 26 (18) 12* (10)
Peeling 61 (11) # ( – ) 11 (7)
# not recorded
* of 126 subjects

Orally and parenterally administered clindamycin has been associated with severe colitis which may end fatally. Cases of diarrhea, bloody diarrhea and colitis (including pseudomembranous colitis) have been reported as adverse reactions in patients treated with oral and parenteral formulations of clindamycin and rarely with topical clindamycin (see WARNINGS).

Abdominal pain, gastrointestinal disturbances, gram-negative folliculitis, eye pain and contact dermatitis have also been reported in association with the use of topical formulations of clindamycin.

Read the entire FDA prescribing information for Clindacin P (Clindacin Topical Solution)


Skin Health: 15 Tips for Clear Skin See Slideshow

© Clindacin P Patient Information is supplied by Cerner Multum, Inc. and Clindacin P Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors